Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients
about
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomicsPharmacogenomics of hypertension and heart diseaseDiscovery of novel GPVI receptor antagonists by structure-based repurposingPolymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infectionGenetic polymorphisms of platelet receptors in patients with acute myocardial infarction and resistance to antiplatelet therapy.Prakriti (Ayurvedic concept of constitution) and variations in platelet aggregation.Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acidVariability and persistence of aspirin response in lower extremity peripheral arterial disease patientsImpact of genetic polymorphisms on clinical response to antithrombotics.Pharmacogenetics of aspirin resistance: a comprehensive systematic review.Pharmacogenetics of cardiovascular drug therapy.The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.
P2860
Q26801867-9CFC36C2-68B4-4441-ADA6-5B9BB4DD6C93Q26822796-B044108F-7A12-4610-A7E0-3FB398BAF995Q27015722-246E6BD3-D995-49C8-BE9E-5FE0002FAB7BQ28540147-2F4B3210-4AE7-428B-A853-DA4A3666DED1Q33398521-CB8E5A59-BAB5-490B-B718-1F288581A279Q34113879-D3FC3EB0-959A-4D34-9D7B-8D6DF729659CQ34507730-45F6575B-7187-4723-AB5A-335FBFEAB838Q34974280-5C77B80B-6833-4B93-9084-236D9B9BF9FBQ35400988-EAE95E45-2B82-43D1-9FFB-2F92236E973DQ36441477-3BEC6FA9-8848-4454-8F15-900A8A8EBECDQ37145122-8353B4DD-8F9B-4211-8DAF-5A8A05BC8170Q37430401-0EE4E146-25DF-4EBB-BD86-8D8DE87851C1Q38120047-2121EFAC-44BF-4C0A-83B1-F7B2E1459E32
P2860
Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@ast
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@en
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@nl
type
label
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@ast
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@en
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@nl
prefLabel
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@ast
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@en
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@nl
P2093
P50
P356
P1476
Polymorphisms of COX-1 and GPV ...... ronary artery disease patients
@en
P2093
Julio C Reséndiz
Jussi Mikkelsson
Leena Viiri
Pekka J Karhunen
Riitta Lassila
P304
P356
10.1160/TH05-07-0516
P407
P577
2006-02-01T00:00:00Z